天域生物: 关于最近五年被证券监管部门和交易所采取监管措施或处罚情况及整改情况的公告

Core Viewpoint - Tianyu Biotechnology Co., Ltd. has announced that it has not faced any penalties from regulatory authorities or exchanges in the past five years, while also detailing the measures taken in response to previous regulatory actions against its controlling shareholder and a subsidiary [1][2][4]. Recent Regulatory Actions and Rectification - The company’s controlling shareholder, Luo Weiguo, received a public reprimand from the Shanghai Stock Exchange for failing to disclose changes in shareholding timely, which resulted from a dilution of shares due to a non-public stock issuance [2]. - The company was subject to administrative regulatory measures by the China Securities Regulatory Commission (CSRC) for inadequate impairment provisions related to a long-term equity investment, which violated accounting standards [2][4]. - The company has established a special rectification working group to address the issues, ensuring compliance with accounting standards and improving governance structures [3][4]. - The former financial director, Sun Weidong, received a regulatory warning for inaccuracies in financial disclosures and has since resigned from his position [4]. - The company has confirmed that its current directors and senior management have not faced any administrative penalties from the CSRC in the last three years [5].